Zobrazeno 1 - 10
of 22
pro vyhledávání: '"I. A. VАSILYEVА"'
Autor:
I. A. Burmistrovа, E. V. Ezhovа, Kh. B. Dаdаshevа, E. V. Vаniev, O. V. Lovаchevа, I. A. Vаsilyevа
Publikováno v:
Туберкулез и болезни лёгких, Vol 99, Iss 11, Pp 66-71 (2021)
The article describes a clinical case of a female patient with respiratory tuberculosis exposed to several cases of extensive drug resistance in their family. Tuberculosis progressed in this patient due to the late initiation of adequate treatment. T
Externí odkaz:
https://doaj.org/article/3f892c5c5d394b28ad0aa8299265c96e
Autor:
A. О. Mаryandyshev, A. I. Kulizhskаya, E. S. Khimovа, D. V. Perkhin, O. M. Sveshnikovа, S. E. Presnovа, N. P. Kurochkinа, A. S. Sotnikov, N. A. Leschevа, I. A. Vаsilyevа
Publikováno v:
Туберкулез и болезни лёгких, Vol 97, Iss 7, Pp 5-10 (2019)
In 2016, World Health Organization published new guidelines for the treatment of multiple drug resistant tuberculosis (MDR TB), which stated that minimum duration of treatment was 9 months. In the Russian Federation, it is impossible to use short cou
Externí odkaz:
https://doaj.org/article/12e5b60048f6476b89056829f71e6ef8
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 10, Pp 13-19 (2018)
The objective of the study: to assess the efficiency of therapeutic discrete automated plasmapheresis in the management of hepatotoxic reactions, developed in tuberculosis patients with multiple and extensive drug resistance, including those with con
Externí odkaz:
https://doaj.org/article/9573b86d5228410ca493bb5943454959
Autor:
D. V. Vаkhrushevа, I. A. Vаsilyevа
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 9, Pp 57-62 (2018)
The article describes the main issues related to the provision of quality of laboratory tests aimed to diagnose tuberculosis and monitor the efficiency of its treatment in the Russian Federation. It speculates on the organization of laboratory diagno
Externí odkaz:
https://doaj.org/article/5b7e08ea6cb44b42b9556659904c61e0
Publikováno v:
Туберкулез и болезни лёгких, Vol 96, Iss 2, Pp 22-26 (2018)
The objective: to evaluate the efficiency of chemotherapy with bedaquiline in pulmonary tuberculosis patients with multiple drug resistance Subjects and methods. The chemotherapy efficiency was studied in 70 tuberculosis patients with extensive (XDR)
Externí odkaz:
https://doaj.org/article/2abaae790cd44ea186657064c3af0ca1
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 11, Pp 63-66 (2017)
The objective of the study is to compare the efficiency of chemotherapy in new pulmonary tuberculosis patients depending on the time when multiple drug resistance was detected.Materials and subjects: 89 new patients with pulmonary tuberculosis were e
Externí odkaz:
https://doaj.org/article/fd6042768a3442d68b07f06ead304a03
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 9, Pp 8-18 (2017)
The article presents the data on the formation of the WHO global statistics on tuberculosis with concurrent HIV infection, which is given in the Global TB Reports. The information published on this issue in the WHO Global Reports for the WHO regions
Externí odkaz:
https://doaj.org/article/94caa416fbe44b11ae89246a33faa98e
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 6, Pp 9-21 (2017)
The article presents data on two of the main epidemiological rates defining the burden of tuberculosis in the system of WHO global statistics tuberculosis incidence and mortality.The article specifies the formation of WHO assessment of tuberculosis i
Externí odkaz:
https://doaj.org/article/bc907f93dc7f4759a95bd4b17f999eb0
Publikováno v:
Туберкулез и болезни лёгких, Vol 95, Iss 5, Pp 7-16 (2017)
The purpose of the article is to inform national specialists involved in tuberculosis control about methods for compilation of WHO global tuberculosis statistics, which are used when developing strategies and programmes for tuberculosis control and e
Externí odkaz:
https://doaj.org/article/99dd42ac8bcb486ca29f87bf62518d91
Publikováno v:
Tuberkulez i Bolezni Lëgkih, Vol 99, Iss 7, Pp 41-47 (2021)
The objective: to compare liver function of respiratory tuberculosis patients during the intensive phase of treatment with first line drugs (chemotherapy regimen 1) and reserve drugs (chemotherapy regimens 4 and 5).Subjects and Methods: Data of 144 r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78e9c0a2c65995488dcb6638ab205f14
https://www.tibl-journal.com/jour/article/view/1554
https://www.tibl-journal.com/jour/article/view/1554